Handbook of pharmaceutical manufacturing formulations. (Record no. 70953)

000 -LEADER
fixed length control field 02593cam a22004571i 4500
001 - CONTROL NUMBER
control field 9781315102948
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220531132333.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m d
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 191119s2019 flu o 000 0 eng d
040 ## - Cataloging Source
-- OCoLC-P
-- eng
-- rda
-- pn
-- OCoLC-P
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781315102948
-- (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1315102943
-- (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781351593595
-- (ePub ebook) :
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1351593595
-- (ePub ebook) :
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781138103160 (hbk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781351593601
-- (PDF ebook) :
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1351593609
-- (PDF ebook) :
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781351593588
-- (electronic bk. : Mobipocket)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1351593587
-- (electronic bk. : Mobipocket)
024 7# -
-- 10.1201/9781315102948
-- doi
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)1129692351
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC-P)1129692351
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RS200
082 04 -
-- 615.19
-- 23
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Niazi, Sarfaraz,
Dates associated with a name 1949-
Relator term author.
245 10 - TITLE STATEMENT
Title Handbook of pharmaceutical manufacturing formulations.
Number of part/section of a work Volume two,
Name of part/section of a work Uncompressed solid products /
Statement of responsibility, etc. Sarfaraz K. Niazi.
250 ## - EDITION STATEMENT
Edition statement Third edition.
264 #1 -
-- Boca Raton :
-- CRC Press,
-- 2019.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource
336 ## -
-- text
-- rdacontent
337 ## -
-- computer
-- rdamedia
338 ## -
-- online resource
-- rdacarrier
500 ## - GENERAL NOTE
General note Previous edition: New York: Informa Healthcare, 2009.
500 ## - GENERAL NOTE
General note <P><STRONG>Part I. Regulatory and Manufacturing Guidelines</STRONG></P><P>Chapter 1. U.S. FDA Good Manufacturing Practices</P><P>Chapter 2. Guideline on the Common Technical Document for the Registration of Pharmaceuticals for Human Use</P><P>Chapter 3. Process Validation: General Principles and Practices</P><P>Chapter 4. Bioequivalence Regulatory Compliance</P><P>Chapter 5. Bioequivalence Regulatory Review Process and Audit</P><P>Chapter 6. EU Guidelines to Good Manufacturing Practice: Active Drug Substance</P><P>Chapter 7. FDA Pre-approval Inspections</P><P>Chapter 8. Formulation Factors in Uncompressed Dosage Forms</P><P>Chapter 9: Solid-State Properties.</P><P>Chapter 10: Formulation of Flavor.</P><P><STRONG>Part II. Manufacturing Formulations</STRONG></P><P>Uncompressed Solids Formulations</P><P><STRONG>Part III. Commercial Pharmaceutical Formulations.</STRONG></P><P>Commercial Pharmaceutical Formulations.</P>
588 ## -
-- OCLC-licensed vendor bibliographic record.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Dosage forms.
856 40 -
-- Taylor & Francis
-- https://www.taylorfrancis.com/books/9781315102948
856 42 -
-- OCLC metadata license agreement
-- http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf

No items available.

Technical University of Mombasa
Tom Mboya Street, Tudor 90420-80100 , Mombasa Kenya
Tel: (254)41-2492222/3 Fax: 2490571